Clincosm LogoSign in Get a demo

advanced urothelial carcinoma

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 9, 2023

Advanced Solid Tumors Cancer, Advanced Urothelial Carcinoma, Oral Drug Administration Trial in New York (FX-909)

Not yet recruiting
  • Advanced Solid Tumors Cancer
  • +3 more
  • New York, New York
    Memorial Slone Kettering Cancer Center
Jun 26, 2023

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Advanced Biliary Tract Carcinoma, Advanced Colorectal Carcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial in

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • +32 more
  • Biospecimen Collection
  • +6 more
  • Chicago, Illinois
    Northwestern University
Feb 6, 2023

Advanced Urothelial Carcinoma Trial in Boston (copanlisib, Avelumab)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Boston, Massachusetts
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain,
Jan 13, 2023

Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,

Recruiting
  • Advanced Bile Duct Carcinoma
  • +33 more
  • Sacramento, California
  • +6 more
Aug 11, 2022

Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

Recruiting
  • Advanced Urothelial Carcinoma
  • +3 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Jun 28, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Advanced Urothelial Carcinoma Trial in Beijing (anti-PD-L1 antibody, albumin bound paclitaxel)

Active, not recruiting
  • Advanced Urothelial Carcinoma
  • anti-PD-L1 antibody
  • albumin bound paclitaxel
  • Beijing, Beijing, China
    Beijing Tumor Hospital
Jan 20, 2022

Urothelial Carcinoma Recurrent, Advanced Urothelial Carcinoma Trial in San Francisco, Buffalo (Vactosertib(TEW-7197)/

Not yet recruiting
  • Urothelial Carcinoma Recurrent
  • Advanced Urothelial Carcinoma
  • Vactosertib(TEW-7197)/ Durvalumab
  • San Francisco, California
  • +1 more
Sep 22, 2021

Advanced Melanoma, Advanced Urothelial Carcinoma Trial in Beijing (TWP-101)

Recruiting
  • Advanced Melanoma
  • Advanced Urothelial Carcinoma
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Jul 20, 2021

Advanced Urothelial Carcinoma Trial in Daegu, Daejeon, Seoul (GCb, GemOx)

Unknown status
  • Advanced Urothelial Carcinoma
  • Daegu, Korea, Republic of
  • +4 more
Sep 22, 2014